Dr. Joseph Ting is Clinical Associate Professor in the Division of Neonatology, Department of Pediatrics, University of British Columbia and Staff Neonatologist at BC Women’s Hospital. He completed his Residency in Pediatrics at Queen Mary Hospital, University of Hong Kong, in 2006 and obtained his Postgraduate Diploma in Infectious Diseases and Master of Public Health (Medical Statistics) from the University of Hong Kong in 2007 and 2009, respectively. In 2010 – 2013 he received his fellowship training in Neonatal-Perinatal Medicine in Vancouver, six months of which was spent at The Hospital for Sick Children in Toronto to receive further training in Targeted Neonatal Echocardiography (TnECHO).
Dr. Ting’s main research interests fall into two aspects: (i) neonatal infections & antimicrobial stewardship; and (ii) small-for-gestational infants. He is interesting in conducting (i) population studies to understand their associations with predictive variables and neonatal outcomes; and (ii) targeted neonatal echocardiography studies to describe their haemodynamic changes to develop supportive strategies to these vulnerable infants.
Multi-drug-resistant organisms and neonatal outcomes
Right ventricular dysfunction in infants with congenital diaphragmatic hernia
Myocardial dysfunction in preterm infants with septic shockGrants
2017 - Medical and Allied Staff Engagement Society (MASES) Engagement Fund, Provincial Health Services Agency (PI)
2016 - Pan-Canadian Network to Improve Outcomes of Preterm Birth (team grant), Canadian Institute of Health Research (Co-applicant)
2017 - Establishment Award, British Columbia Children’s Hospital Research Institute (PI)Honours & Awards
2016 - Early Career Investigator Award, Canadian Neonatal Network
2016 - Best Young Investigator Prize, Hong Kong College of Paediatricians
2017 – Early Career Investigator in Women’s Health Research Award, British Columbia Women’s Hospital Research InstituteResearch Group Members
Sophia Sidi, Research Assistant, RSV Program Research Coordinator
Antibiotics are the most commonly prescribed class of medications in the neonatal intensive care unit (NICU) for good reason: in preterm infants, infections are difficult to diagnose and can quickly become life-threatening.